Integra Therapeutics
Main focus: Gene editing for the treatment of genetic diseases
Company stage: Pre-clinical
Diseases: Undisclosed
Genome editing tool: Undisclosed
Funding stage: Private
Location: Barcelona, Catalonia, Spain
Website: https://integra-tx.com/
Integra Therapeutics is a start-up company focused on next-generation gene writing. The technology is based on the CRISPR system, which has been merged with transposase and integrase proteins that have a great capacity for gene transfer. Thus, the system does not depend on viral vectors for transporting the gene-editing components into the cell. The company yet has to disclose the specifics of the technology, as well as its lead therapeutic candidates.